top of page
Search

MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health

  • MVT
  • Mar 29, 2018
  • 1 min read

Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.


 
 
 

Recent Posts

See All

Comments


Commenting on this post isn't available anymore. Contact the site owner for more info.
  • LinkedIn
bottom of page